#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thermal burn B-cell lymphoma refractory Osteosarcoma Acute myeloid leukaemia refractory Germ cell cancer Chondrosarcoma Chronic inflammatory demyelinating polyradiculoneuropathy Hyperadrenocorticism CDKL5 deficiency disorder Fibrodysplasia ossificans progressiva T-cell lymphoma Neutropenia Follicular lymphoma stage II Liposarcoma Small for dates baby More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Basic Information Testicular leiomyosarcoma – Life with Disease Skin angiosarcoma – Diagnostics Haemolytic uraemic syndrome – Diagnostics Ocular melanoma – Treatment Small intestine leiomyosarcoma – Trials in Disease Loeys-Dietz syndrome – Diagnostics Primary biliary cholangitis – Trials in Disease Phenylketonuria – Trials in Disease Vascular malformation More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-23A-116 Dotatate Ag-946 F125/10 Cefuroxime Axetil Quercus Robur Pollen Extract Cpk850 Letrozole Lomustine Rmc-035 [11C]Az14193391 Gskvx000000008866 Mitazalimab Sodium Iodide (131I) SPY002 Pomalidomide Brimonidine Loncastuximab Tesirine Lidocaine Galcanezumab More therapies…

    Learn about Your Condition

    Ovarian cancer stage IV Kearns-Sayre syndrome Acute cardiac event Pancreatic carcinoma Psychotic disorder Choroidal dystrophy Adenovirus infection Acute promyelocytic leukaemia Dengue fever Hepatorenal syndrome Uveitis Amyotrophic lateral sclerosis Emphysema Macular telangiectasia Schizophreniform disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac valve disease

  • A Study of Intravenous Lidocaine to Reduce Inflammation in Patients Undergoing Heart Valve or Coronary Artery Bypass Surgery with Heart-Lung Machine

    Recruiting

    2 1 1
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    Spain
  • Study Comparing Apixaban and Carbasalate Calcium for Patients with Aortic Valve Replacement Due to Heart Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac valve disease
    Investigated Drugs:
    • Apixaban
    • Carbasalate Calcium
    France
  • Study on Propofol and Remifentanil for Patients with Heart Disease Undergoing Cardiac Anesthesia with Cardiopulmonary Bypass

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic disorder
    • Cardiac valve disease
    • Coronary artery disease
    Investigated Drugs:
    • Remifentanil
    • Propofol
    Austria

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!